Eric Woolf
Dr. Woolf currently directs the Clinical Regulated Bioanalysis Group of Merck Research Laboratories, West Point, PA. He received his B.A. in Chemistry from LaSalle College in 1982, and a Ph.D. in Analytical Chemistry from Seton Hall University in 1986. From 1986 to 1990 he was a member of the Drug Metabolism/Pharmacokinetics Dept. of Berlex Laboratories. He joined Merck Research Laboratories in 1990 as a research fellow. Dr. Woolf and his group have supported numerous clinical development projects that have led to the successful registration of Merck compounds. Since 1986, he has authored or co-authored over 50 research papers pertaining to bioanalysis and pharmacokinetics. His major research interests include the utilization of novel HPLC approaches in bioanalysis and the bioanalysis of unstable compounds.
What three things would you take if you were stranded on a desert island?
- A satellite phone with solar charger
- a flint and striker
- a case of duct tape
If you weren’t a bioanalysts what would you be?
- Either a computer repair person or a genealogist
What is your favorite city?
- London
Why have you decided to become a Zone Leader?
To stay connected with the bioanalytical community.
Issues facing the bioanalytical community: summary of round table discussions
2013 White Paper on recent issues in bioanalysis: ‘hybrid’ – the best of LBA and LCMS
2012 White Paper on Recent Issues in Bioanalysis and Alignment of Multiple Guidelines
2011 White Paper on Recent Issues in Bioanalysis and Regulatory Findings from Audits and Inspections